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THE mode ofgrowth of transplantable ascites tumours can be determined with
some accuracy. Tumour cells at any point in time can be easily counted since
most of them are free in the peritoneal cavity and so may be withdrawn for study.
It has been possible to define clearly the growth pattern of tumours growing from
large inocula, in situations where the hosts rapidly succumb (Klein and Revesz,
I 953; Patt and Blackford, 1954; Laird, 1964). However when the inoculum is
small or when the inoculated host is in process ofdeveloping immunity the pattern
of growth is less certain. When tumour cells are few host cells may outnumber
them by some hundredsoftimes. Moreover slight variations in the size of a small
inoculum may mean great differences in the ultimate fate of host and tumour.
Using tumour cells obtained directly from animals one can never be certain about
the effective size ofan inoculum, for not all inoculated cells are viable, particularly
if they have been washed carefully beforehand in saline solutions to remove
unwanted materials from the previous host (Gillo and Wirtheimer, 1966). Never-
theless a study of tumour behaviour might be instructive in situations where the
host need not necessarily succumb, for it is in these situations that host reactions
against the tumour are most nearly successful, and perhaps most obvious and
easily investigated.
This paper describes growth patterns of the Landschuitz ascites tumour (LAT)
in normal and resistant mice, using relatively small inocula. It was possible to be
fairly certain about the viability of the cells in these inocula since the LAT was
maintained in vitro before inoculation. Maintained in this way, the cells retained
high mouse virulence (Postlethwaite and MacPherson, 1963) while growing nearly
exponentially and at a very constant rate. Since they did not adhere to the
culture vessel, but floated in free suspension, the tumour cells could be quickly
prepared for animal inoculation. without recourse to washing, yet free from
contamination from previous hosts. LAT growin in vitro proved a plentiful,
predictable, easily handled commodity.
The resistant mice received a single large dose ofheavily irradiated Landschiitz
cells. The resistance which develops afterinoculation ofirradiated cells is generally
accepted as being immunological in nature (Donaldson and Mitchell, 1959; McKee
et al., 1959; Revesz, 1960; Scott, 1961) and in these experiments, involving a long
established tumour line of wide host range, the immunity was almost certainly
evoked by transplantation antigens (Klein, 1959). The use of a single dose of
irradiated cells made it possible to study with some precision the time course of
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MATERIALS AND METHODS
Animals.-Adult male random-bred TO mice of mean weight 25 g. were fed
pellet Diet FFG (E. Dixon & Sons, (Ware) Ltd., Ware, Herts.) and water. They
were divided into 4 groups of about 50 mice each, called 0, II, IV and VII. Those
in groups II, IV and VII all received 1 2 x 106 heavily irradiated LAT cells by
intraperitoneal injection and this was followed by intraperitoneal challenge with
3 X 104 viableLAT cells. The interval between irradiated inoculum and challenge
was 2 days in group II, 4 days in group IV and 7 days in group VII. The control
group, group 0, received the challenge alone. 3 x 104 cells was a suitable size of
challenge because it killed about 9500 of such control animals. Thus even slight
degrees of protection in the other groups were likely to be detected.
The tumour's course was measured (i) by counting the number of cells in the
peritoneal cavity; (ii) by weighing the mice daily, for a rough index of the onset
and progress of ascites; (iii) by noting the time between challenge and death; and
(iv) by noting the percentage ofmice surviving in each group.
Peritoneal cavity cell counts.-On the 3rd, 5th, 7th, 10th and some subsequent
days after challenge, 3 to 5 mice from each group were killed by cervical disloca-
tion. The number of cells in each peritoneal cavity was obtained by multiplying
together its cell concentration and its volume. Peritoneal fluid volume was
deduced from its mass, found by weighing the carcase before and after carefully
swabbing the cavity with cotton wool. It is legitimate to assume a specific gravity
of 1.00 for peritoneal fluid for the first 12 days after challenge, the value for a pool
of samples from 5 mice being 1 003 on the 12th day. The cell concentration of
each peritoneal cavity was obtained by withdrawing 0-1 ml. of fluid into a tuber-
culin syringe, diluting with 0.1% Trypan Blue in isotonic saline and counting
immediately on a Fuchs-Rosenthal chamber. When the volume of peritoneal
fluid was very small, 0.1 ml. could not be withdrawn until 1-0 ml. isotonic saline
had been injected into the cavity. All punctures of the peritoneum were made
through the abdominal wall after reflection of the skin. In every case, before
withdrawing the sample for counting the abdomen was massaged between finger
and thumb four times per second for 30 seconds.
No attempt was made to differentiate between tumour and host cells save that
only the large cells in the counting chamber were considered. Comparison with
Giemsa-stained smears showed that the
"large cell " count included macrophages
and some large lymphocytes as well as tumour cells, but small lymphocytes and
polymorphs were excluded. The difference between large and smaller cells was
quite distinct. Counts were made of large cells from the peritoneal cavities of 6
entirely untreated mice. The mean value, 3-44 x 106 (SD= 188 x 106),
defined the baseline above which tumour growth or host cell reaction could be
assessed.
Cell line.-LAT cells were grown in 60 mm. glass Petri dishes as described by
Postlethwaite and MacPherson (1963). The medium (ETC/80. 10. 10) consisted
of modified Eagle's medium (80%)supplemented with heat-inactivated calf serum
(10%), tryptose phosphate broth (10%) and antibiotics (penicillin 100 units per
ml.; streptomycin 100,ug. per ml.; mycostatin 50 ,g. per ml.). Cultures were
incubated at 370 C. in an atmosphere of 500 CO2 in air.
When the concentration of cells in a dish approached 106 per ml. the cells
were brought into homogeneous suspension by gentle refluxing with a Pasteur
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pipette. Some were then withdrawn, diluted in fresh medium, and transferred
to a new dish at a concentration of 3 x 104 per ml. By regular passage from dish
to dish like this, it was possible to maintain, throughout the period of the experi-
ments, a stock ofcells foranimal inoculation whose concentration never rose above
2 x 106 per ml. nor fell below 3 x 104 per ml. This is the range in which growth
is most nearly logarithmic, and very constant (Fig. 1). The mean generation time
was 18-8 hr (95% confidence limits 16*5-21*1 hr).
Irradiation.-3000 r. were delivered to the cells at 103-106 r. per minute by a
therapeutic X-ray machine operating at 230 kv and 15 mA. The beam was
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FIG. 1.-Growth of LAT in vitro over a period of 55 days, during which cells from this line were
used for animal inoculation as described in the text. Horizontal axis: days of in vitro
growth. Vertical axis: calculated cumulative yield of cells (log1o) from " day 0 ", when the
cell line was already in its 18th passage in vitro. The position of each point was calculated
from the cell concentration at the time of passage and the cumulative dilution factor.
M.G.T. = Mean generation time.
filtered with 1 mm. Cu and 1 mm. Al. During irradiation the cells were sus-
pended in 20 ml. ETC/80. 10. 10 in a 10 cm. Petri dish with the lid on, at room
temperature and in equilibrium with atmospheric air. For maximum backscatter
the dish was placed on a 10 cm. high stack of " Mix-D " blocks. X-ray dose was
checked with a Baldwin Farmer Secondary Standard X-ray Dosemeter. 3000 r.
did not destroy LAT cells immediately, as checked by exclusion of Trypan Blue,
but prevented them from undergoing more than 1 or 2 subsequent divisions.
The X-ray sensitivity of LAT growing in glass was shown to be similar to that of
other mammalian cells (Puck et al., 1957) with a D37 value of 135 r. This value
implies that less than 1 in 109 cells irradiated with 3000 r. would be expected
to survive.
Preparation of inocula.-All inocula were in 0-2 ml. ETC/80. 10. 10 and were
delivered by a tuberculin syringe. Cell concentration was checked immediately
before inoculation and again, in the residue, immediately afterwards. These
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counts never differed by more than 5%. Challenge inocula could be prepared
rapidly, adjustment to the required concentration and inoculation of 50 mice
requiring no more than 45 minutes. This was the maximum period during which
challenge cells were exposed to room temperature and low pCO2. Irradiated
inocula took longer to prepare, but the cells were always inoculated within an
hour of the end of irradiation. Irradiation itself never produced a significant
immediate change in cell concentration.
RESULTS
The results showed that, depending on the state of the host at the time of
challenge, the tumour may grow progressively or show little evidence of growth
at all. There was no evidence for regression ofadvanced tumour, nor for retarded
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FIG. 2.-Peritoneal cell counts, plotted against time after challenge, of mice receiving the
challenge inoculum only (Group 0), and of those challenged 2 days (Group II) and 7 days
(Group VII) after immunization. Each symbol is the mean count oflarge cells for 3 to 5 mice
of the group indicated. The vertical lines indicate standard deviation and the parallel
horizontal lines represent mean cells per untreated mouse with 95% confidence limits. To
avoid superimposition some symbols have been shifted slightly laterally on days 3, 5, 7
and 12.
growth of tumour in its ascitic form, but solid tumours appeared late in some
animals that failed to develop ascites. The results ofperitoneal cavity cell counts
for groups 0, II and VII are shown in Fig. 2 and the order of spontaneous deaths
for all groups in Fig. 3. Weight gains of mice in all groups are plotted in Fig. 4.
Because of the high background of host cells the peritoneal cell counts were
not meaningful up to the 5th day after challenge. Beyond the 12th day afterA. H. WYLLIE AND R. POSTLETHWAITE
challenge they again ceased to define tumour size since many cells were inacces-
sible to the method, being bound in loose fibrinous clots within the cavity or
infiltrating extensively beyond it. In the meaningful range from the 5th to 12th
day there was a clear difference between the cell counts from group 0 animals
(challenge only) and those from group II animals (challenge 2 days after irradiated
cells). On the 10th day after challenge this difference amounted to 300 million
more cells per cavity in group II mice, more than a two-fold excess. It was
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FIG. 3. Percentage survival of mice plotted against time after challenge. Only those mice are
considered which were not killed deliberately for peritoneal cell counts, and nlo such
executions were carried out in any group after the onset of spontaneous deaths.
O Group 0: challenge only (13 mice)
A -Group II: challenge 2 days after immunization (22 mice)
ij =Group IV: challenge 4 days after immunization (20 mice)
i -Group VII: challenge 7 days after immunization (19 mice)
probably a genuine difference in tumour cell growth, and contributed to the
shorter survival time ofthe animals in group II. The onset ofascites, as indicated
by rapid weight gain, occurred in both groups at the same time: the 11th day after
challenge.
Group VII animals never showed convincing evidence of tumour cell growth.
The small rise in number of peritoneal cavity cells seen in Fig. 2 probably repre-
sented an increase in host macrophages and large lymphocytes, since it occurred to
a similar extent in animals given a sham challenge ofmedium ETC/80. 10. 10 only,
7 days after the irradiated inoculum (Table I). Although on the 5th day after
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TABLE I.-Peritoneal Cell Counts in Mice of Group VII and in Similarly
IMMUnisecd Mice Challenged After 7 Days With Medium Only
Days after
challenge
3
5
7
Mean total large cells x 106
1 ~ A
1
Group VII
9*46 (4*)
16-00 (5)
14 75 (5)
Sham
9 56 (4)
9-06 (4)
11-50 (3)
* Figures in brackets indicate numbers of mice.
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FIG. 4.--Mean increase in mouse weight plotted against time after challenge
* completely untreated mice
o Group 0: challenge only
A Group II: challenge 2 days after immunization
I Group VII: challenge 7 days after immunization
O Group IV: challenge 4 days after immunization. Those mice in this
group which eventually developed ascites are plotted separately
.............) from those which did not (.- - - - - - - - - -
To simplify the diagram the results between days 3 and 10 are plotted for Group IV only.
The other groups gave closely similar results during this period. Standard deviations were
proportionately similar for all points and have been shown (vertical bars) for Group IV mice
only on the 18th day after challenge. The baseline (0 weight increase) is the mean weight
for the mice in each group measured over a period of 5 days immediately following challenge.
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sham challenge the peritoneal cell count was significantly less than after the
standard challenge with viable cells, this difference might have been expected
since mice in group VII were exposed twice to LAT cells while the sham-challenged
mice were exposed only once. Group VII mice gained weight no more quicklv
than completely untreated mice ofthe same age, and remained apparently healthy
for 3 weeks after challenge.
Ofthe animals in group IV which were not killed for cell counts, half (10 of 20)
succumbed to tumour, showing increasing numbers of cells in the peritoineal
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anlidtmalngoups wich behaved inete stamhedwa as theresistnteranimals oftgrou VII,-
wtasit norsign tumour growthcor The firs3wes afterachallenge (Fig.nta4)
of mice which developed no ascites in the first 30 days after challenge, and the
slightly lower percentage which survived "indefinitely " (scored on the 100th
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TABLE II.-Mouse Resistance Shown by Absence ofAscites at 30 Days
or ofSolid Tumnour at 100 Days After Challenge
Percent resistant mice as determined by
Days between Number
immunization of Absence of ascites Absence ofsolid tumour
and challenge mice at 30 days at 100 days
Not immunized 13 8 8
2 )9! .5 0
4 20 50 20
7 19 100 58
day after challenge) without developing solid tumours. There was a rapid rise in
these percentages as the time interval between irradiated inoculum and challenge
increased from 2 to 7 days. This almost certainly represented the development of
specific immunity to the tumour challenge, beginning between 2 and 4 days after
the antigenic stimulus of irradiated cells.
This immunity was long-standing. One hundred days after the initial chal-
lenge 5 mice from group VII which had developed neither ascites nor solid tumours
were challenged again intraperitoneally with 105 viable in vitro cultured LAT cells.
Four more otherwise completely untreated mice received the same challenge.
All the mice in the first group survived; all those in the second died with ascites
before the 25th day after challenge.
DISCUSSION
These results demonstrated two main points. First, resistance developed
rapidly after the inoculation of irradiated cells and its onset, following 2 days'
latency, was similar to that shown for primary immunological reactions in other
situations. Examples include the appearance of circulating antibody in mice
after implantation of tumour homografts (Gorer, Mikulska and O'Gorman. 1959)
and the mononuclear cell response in rats bearing first set skin homografts (Gowans.
McGregor and Cowen, 1963). A similar time course was observed by Scott (1961)
using in vivo cultured Ehrlich ascites carcinoma in mice immunized with a single
dose of irradiated cells. It is thus likely that the resistance demonstrated in the
experiments reported here was immunological in nature. Secondly the absence
of intermediate growth patterns, such as delayed or slowed tumour development.
or regression from advanced stages was remarkable; the ascites tumour either
grew progressively or showed no sign of growth, apparently depending on the
immunological status of the host at the time of challenge. Adoption of a solid
form seemed to be the only course open to the tumour growing in partially immune
animals. These findings may cast some light on the nature of the processes
involved in rejection of transplantable ascites tumours.
It is a well-known but intriguing problem that animals which are potentially
capable of rejecting an ascites tumour regularly fail to do so unless previously
immunized against the tumour (Gross, 1943; Molomut, Gross and Padnos. 1963;
Apffel et al.. 1966). Recently it has become clear that even in unimmunized
animals a substantial host response follows inoculation with tumour cells. This
response has a time course similar to that in other primary homograft reactions
and to the development ofimmunity following injection ofirradiated tumour cells.
Thus monocytes appear in the mesenteries in increasing numbers from the 3rd day
onward (Wheatley and Ambrose, 1964) and splenic hypertrophy (Stuart and el
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Hassan, 1964a) is accompanied by an increase in oncocidal activity of spleen cells
on transplantation (Stuart and el Hassan, 1964b). However, though much ofthis
host response occurs before clinically obvious illness or ascites, it is inadequate to
stop the growth of the tumour. It is tempting to assume that this inadequacy is
purely quantitative, the tumour cells being so numerous or so prolific that the host
reaction fails to contain them unless it is " given a start " by means of immuniza-
tioIn. Such simple reasoning, however. does not explain all experimental findings.
including some reported here.
We may suppose that tumour regresssion depends on there being sufficient
oncocidal material available in the host to destroy (or prevent multiplication of)
all the tumour cells present. By the simple assumption above, this condition for
regression could be met in either of two ways. First, it is possible that host
oncocidal material is produced at a limited rate insufficient to overtake the rapidly
proliferating tumour cells once their growth is established. Regression of tumour
would then depend oni there being sufficient oncocidal material available at the
time of challenge to destroy all the inoculated cells. Immunization would be
interpreted as increasing the quantity of this material. WAere this interpretation
correct, however, a different pattern oftumour growth would have been observed in
animals challenged while developing immunity. Such animals comprised group
IV. where the balance between host reaction and tumour growth must have been
delicate. Halfthese animals survived while halfsuccumbed with ascites, although
all were initially similar and received the same treatment. The surviving animals
would be interpreted as those with just sufficient oncocidal material to quench
the tumour at the time of challenge. The remainder would be those with quanti-
ties of available oncocidal material just insufficient to destroy all inoculated
tumour cells. This interpretation requires, however, that in some of these
animals at least a large proportion of the inoculated tumour cells would be
destroyed, leaving only a remnant to grow out and eventually kill the host. This
would be expected to have resulted in delayed tumour cell growth, late onset of
ascites and lengthened survival time. These were not the features of the animals
succumbing in group IV; this first interpretation is unlikely to be correct.
The condition for regression could be met in a second wav. The host material.
though incapable of containing the tumour at the time of challenge might be
produced rapidly enough thereafter to overtake it in its course. Animals eventu-
ally succumbing, including those not immunized, would be interpreted as those
in which the tumour was not overtaken by the timedeath supervened. Immuniza-
tion would be interpreted as decreasing the disproportion between numbers of
tumour cells and host oncocidal material at the time of challenge, i.e. decreasing
the tumour's
- lead ". This interpretation again fails to account for the growth
pattern of tumour in animals challenged whilst developing immunity. Were it
correct the succumbing animals in group IV would be those in which the tumour
just succeeded in killing the host before being overcome itself. whilst the survivors
would be those in which the tumour was overcome at an advanced stage ofgrowth.
There was no evidence for this; regression of ascites must be a very rare pheno-
menon, though it has occasionally been reported in partially immune animals
(Bismanis, 1964). Thus the second interpretation is not substantiated. It can
be made compatible with the results however by postulating that the tumour must
be overtaken not only before death, but before some critical stage in the first few
days after challenge. Growth followed by regression could. have occurred in this
556ASCITES TUMOUR GROWTH IN NORMAL AND RESISTANT MICE 557
period undetected by the methods used. The essence of the critical stage would
be that, once reached, all the surviving cells of the tumour would be protected
thereafter, regardless of the magnitude of the host reaction. The notion of an
irreversible stage in ascites tumour growth is not new (Klein, 1959), but there is
now experimental evidence to support it. Hartveit (1964) noted a rising titre of
oncolytic inhibitor in ascitic fluid in the course ofstudies which also suggested that
the ascites tumour cells themselves were sensitized (Hartveit, 1965). Recently
Apffel et al. (1966) showed that removal of the ascitic fluid from tumour-bearing
mice may induce regression of the residual tumour. This elegant experiment
strongly suggested that ascitic fluid contained some agent protective to the
tumour cells.
Revesz (1955) was the first to study the potentiation of tumour growth in the
presence of degenerating irradiated cells. He suggested this might be due to
leakage of growth-promoting substances from these cells. It is equally plausible
that the irradiated cells remove by absorption growth inhibiting substances
normally present in the cavity.
The development of solid tumours in partially immune animals is reported in
the literature (Stuart and el Hassan, 1964b; Bismanis, 1964). These tumours
may occur frequently in all mice challenged with ascites tumours (BaiJlif, 1954) but
escape detection because of their small size when the animals die with ascites.
Their presence in animals which fail to develop ascites is noteworthy. This may
be due to undefined anatomical factors or to immunological differences. Certainly
the surface properties of solid and ascites tumours from the same subline are
known to differ (Schleich, 1954).
CONCLUSIONS AND SUMMARY
1. Growth patterns ofthe Landschutz ascites tumour in normal and immunized
mice were studied by peritoneal cell counts, weightgain, death timesand percentage
survival.
2. Using in vitro cultured LAT, and producing immunity by means of a single
dose ofirradiated cells, it was possible to define very precisely the immunizing and
challenge doses of tumour cells and the immunological status ofthe host.
3. Immunity began to develop rapidly between 2 and 4 days after the inocula-
tion of irradiated cells. This agrees well with the results of other workers using
in vivo cultured cells of different strains.
4. Although there was evidence of potentiation of tumour growth when
challenge was made 2 days after the irradiated cells, there was no sign ofretarded
growth, or late regression in other animals challenged whilst developing immunity.
The absence of intermediate patterns of this type is discussed and interpreted as
supportive evidence for a critical stage early in the tumour's in vivo sojourn.
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